Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Cooling Treatment After Cardiac Arrest Found Cost-Effective

By HospiMedica International staff writers
Posted on 18 Aug 2009
Therapeutic hypothermia, a brain-preserving cooling treatment, is a cost-effective way to improve outcomes after out-of-hospital cardiac arrest, claims a new study.

Researchers at the University of Pennsylvania (Penn, Philadelphia, USA) used a complex mathematical design to measure quality-adjusted survival after cardiac arrest, cost of hypothermia equipment and treatment, and cost of posthospital discharge care. Factors affecting costs included additional nursing care required during cooling treatment, extra time spent in the intensive care unit (ICU), and postdischarge care required. The model inputs were determined from published data, cooling device companies, and consultation with resuscitation experts. Sensitivity analyses and Monte Carlo simulations were performed to identify influential variables and uncertainty in cost-effectiveness estimates.

The researchers found that according to the model, post-cardiac-arrest patients receiving therapeutic hypothermia gained an average of 0.66 quality-adjusted life year (QALY) compared with conventional care, at an incremental cost of U.S. $31,254. This yielded an incremental cost-effectiveness ratio of $47,168 per QALY. Even at extreme estimates for costs, the cost-effectiveness of hypothermia remained less than $100,000 per QALY. Sensitivity analyses demonstrated that poor neurological outcome and costs associated with posthypothermia care (in-hospital and long term) were the most influential variables in the model. The study was published online ahead of print on August 4, 2009, in Circulation: Cardiovascular Quality and Outcomes.

"There are very few treatments for cardiac arrest victims, and hypothermia stands out as the only therapy which can improve neurologic survival,” said lead author emergency physician Raina Merchant, M.D., M.S. "Hospitals and physicians should promote rapid adoption of this treatment for patients, and cost should not be considered a barrier to use.”

"Having already established that hypothermia improves neurological outcomes after cardiac arrest, we now know that the therapy is also a good use of health care resources,” added Dr. Merchant. "We hope our findings will help more hospitals and insurers to adopt cooling protocols and help more survivors return to productive lives.”

U.S national recommendations that were established in 2005 called for out-of-hospital cardiac arrest patients to be treated with hypothermia when they remain comatose after resuscitation; despite this, many hospitals still fail to offer the intervention. Among the barriers to its use are concerns about its cost, and difficulty coordinating the interdisciplinary resources and staff needed to employ the treatment.

Related Links:
University of Pennsylvania



Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Imaging Table
CFPM200
New
CPAP Machine
EcoStar Auto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.